Abstract
The use of radiation and chemotherapy in the treatment of human malignancy has had a dramatic impact on prolonging the disease-free interval but has not substantially affected long-term patient survival. One reason for this failure is that some tumors respond poorly to either form of treatment or become nonresponsive upon tumor relapse. Since the identification of therapeutic agents has been empirical, the molecular mechanisms that determine treatment effectiveness remain largely unknown.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Cold Spring Harbor symposia on quantitative biology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
